Women's perspectives regarding subcutaneous injections, costs and live birth rates in IVF | Zendy

Anne Musters | Zendy; Esther W. de BekkerGrob | Zendy; Monique H. Mochtar | Zendy; Fulco van der Veen | Zendy; Norah M. van Mello | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Women's perspectives regarding subcutaneous injections, costs and live birth rates in IVF

Author(s) -

Anne Musters,

Esther W. de BekkerGrob,

Monique H. Mochtar,

Fulco van der Veen,

Norah M. van Mello

Publication year - 2011

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/der177

Subject(s) - live birth , medicine , logistic regression , pregnancy , reimbursement , preference , obstetrics , economics , health care , biology , mathematics , statistics , genetics , economic growth

The addition of recombinant LH (rLH) to controlled ovarian hyperstimulation (COH) shows a beneficial effect on ongoing pregnancy rates in poor responder women, with an increase of ongoing pregnancy rate. Next to this possible beneficial effect, there are two potential drawbacks of adding rLH to COH; women have to administer extra injections, and daily rLH injections generate additional costs. We therefore investigated women's perspectives on an additional injection of rLH with respect to live birth rates (LBR) and out-of-pocket costs in a discrete choice experiment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research